会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明专利
    • Novel substrate for determination of blood coagulation factor, and determination using same
    • 用于确定血液凝血因子的新基质和使用其的测定
    • JPS61112096A
    • 1986-05-30
    • JP23374384
    • 1984-11-06
    • Wako Pure Chem Ind Ltd
    • SHINTANI AKINORISUGIYAMA HARUHIKOTANAKA TAKUMINAKAMURA KENJI
    • G01N33/86C07K5/02C07K5/08C07K14/745C12Q1/56
    • Y02P20/55
    • NEW MATERIAL:The compound of formula (R is α-, β-, or γ-amino acid residue which may have protecting group at the N-terminal; A
      1 is α-, β- or γ-amino acid residue or dipeptide residue which may be substituted at the side chain functional group if any; A
      2 is basic amino acid residue) and its salt.
      EXAMPLE: D-valyl-L-prolyl-L-arginyl-4-[N-ethyl-N-(β-hydroxyethyl-)amino]anilide.
      USE: Substrate for the determination of blood coagulant factor.
      PREPARATION: The compound of formula can be prepared e.g. by reacting the C-terminal amino acid having protected amino group and side-chain functional group with N-ethyl-N-(β-hydroxyethyl)-p-phenylenediamine, removing the amino-protecting group, and reacting successively with amino acids according to the amino acid sequence. The decomposition product produced by the contact of the compound with a blood coagulant factor is condensed with a coupler in the presence of an oxidizing agent to effect the color development, and the color is determined by colorimetry to determine the blood coagulant factor.
      COPYRIGHT: (C)1986,JPO&Japio
    • 新材料:式(R是在N-末端可具有保护基团的α-,β-或γ-氨基酸残基; A1是α-,β-或γ-氨基酸残基或二肽残基, 可以在侧链官能团(如果有的话)被取代; A2是碱性氨基酸残基)及其盐。 实施例:D-缬氨酰-L-脯氨酰基-L-精氨酰基-4- [N-乙基-N-(β-羟乙基))氨基]苯胺。 用途:用于测定凝血因子的底物。 制备:式的化合物可以如 通过使具有被保护的氨基的C末端氨基酸和侧链官能团与N-乙基-N-(β-羟乙基) - 对苯二胺反应,除去氨基保护基,并依次与氨基酸反应 氨基酸序列。 通过化合物与血液凝结剂因子的接触而产生的分解产物在氧化剂的存在下与成色剂冷凝以进行显色,并且通过比色法测定颜色以确定凝血因子。
    • 7. 发明专利
    • Process for semisynthesis of human insulin
    • 人胰岛素半胱氨酸的方法
    • JPS5914798A
    • 1984-01-25
    • JP12391782
    • 1982-07-16
    • Wako Pure Chem Ind Ltd
    • SAKATA YOSHITSUGUSHINTANI AKINORIMATSUO TETSUYASUGIYAMA HARUHIKOMINAMII NOBUAKINAGAOKA JIYOUJI
    • C12P21/02
    • PURPOSE: To prepare human insulin from swine insulin, in high efficiency, by using water as the reaction solvent and acromobacter.protease I as the catalyst.
      CONSTITUTION: Swine insulin is made to react with threonine having carboxyl group protected with substituted or unsubstituted alkyl or aralkyl group in water or in an aqueous solution containing a small amount of an organic solvent miscible with water, in the presence of lysyl endopeptidase (Acromobacter.protease I) produced by Acromobacter lyticus at 0W50°C and 4W10pH, preferably under nearly neutral condition, to effect peptide exchange and obtain a human insulin derivative having carboxyl-protected threonine at B
      30 .
      COPYRIGHT: (C)1984,JPO&Japio
    • 目的:通过使用水作为反应溶剂和acromobacter.protease I作为催化剂,高效地从猪胰岛素制备人胰岛素。 构成:在赖氨酰内肽酶(Acromobacter。)存在下,使猪胰岛素与具有被取代或未取代的烷基或芳烷基保护的羧基的苏氨酸在水中或含有少量可与水混溶的有机溶剂的水溶液中反应。 蛋白酶I)在0-50℃和4-10pH,优选在接近中性条件下产生,以实现肽交换并获得在B30具有羧基保护的苏氨酸的人胰岛素衍生物。